Abstract:Staphylococcus aureus is a widespread foodborne pathogen that threatens human health. In particular, multidrug-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) are emerging problems in modern health care, food safety, and animal health, which require the development of new antimicrobials to replace overused conventional antibiotics. Dairy products can potentially act as vehicles for the transmission of S. aureus and other antibiotic-resistant strains from the farm into the general human population, and should be controlled during the production and storage process. Recently, bacteriophage endolysins, which degrade the cell wall that is indispensable for bacteria, have been deemed promising antimicrobial agents. In this study, one endolysin, LysGH15, demonstrated prominent antimicrobial efficacy against S. aureus, as did its catalytic domain, cysteine, histidine-dependent amidohydrolase/peptidases (CHAP) LysGH15 alone. The LysGH15 and CHAP(LysGH15) exhibited different characteristics in one MRSA strain (MRSA 2701), reaching the highest activity under different conditions (35 degrees C and pH 6.0 for LysGH15, 40 degrees C and pH 9.0 for CHAP(LysGH15)). A difference in the sensitivity of LysGH15 and CHAP(LysGH15) to NaCl concentration was found, where the lytic activity of LysGH15 depends strongly on its binding domain's binding capacity, which is positively correlated with the NaCl concentration, whereas the CHAP(LysGH15) activity showed a negative correlation with the NaCl concentration. When the NaCl concentration was 450 mM, the lytic activity of LysGH15 reached its peak, whereas the lytic activity of CHAP(LysGH15) was the highest in the absence of NaCl. The difference in NaCl sensitivity between LysGH15 and CHAP(LysGH15) may be due to the sensitivity of the SH3b binding protein of LysGH15 to NaCl. The CHAP(LysGH1)5 was tested as a biopreservative in whole and skim milk and exerted effective control against S. aureus (declined by approximately 2.5 log(10) cfu/mL when incubated at 4 degrees C for 8 h), which suggests promise for application in dairy products.

The in vitro Antibacterial Activity of Recombinant Human Lysozyme

The molecular modification, expression, and the antibacterial effects studies of human lysozyme

Study on the antibacterial activity of lysozyme hydrolysate

Lactobacillus rhamnosus and Staphylococcus epidermidis in gut microbiota: in vitro antimicrobial resistance

Effect of Dietary Supplementation with Recombinant Human Lysozyme on Growth Performance, Antioxidative Characteristics, and Intestinal Health in Broiler Chickens.

The application of the lytic domain of endolysin from <i>Staphylococcus aureus</i> bacteriophage in milk

The Effect of Lysozyme on Reducing Biofilms by Staphylococcus aureus, Pseudomonas aeruginosa, and Gardnerella vaginalis: An In Vitro Examination

Antimicrobial Activity of Lysozyme Against Oral Pathogens

Antibacterial effect against both Gram-positive and Gram-negative bacteria via lysozyme imprinted cryogel membranes

Bacteriophage Lysins: Antibacterial Effects and Medical Application

Enzyme-coated mesoporous silica nanoparticles as efficient antibacterial agents in vivo

Antibacterial activity of lysozyme after association with carboxymethyl konjac glucomannan

Lysozyme: an endogenous antimicrobial protein with potent activity against extracellular, but not intracellular Mycobacterium tuberculosis

Design and Unique Expression of a Novel Antibacterial Fusion Protein Cecropin B-Human Lysozyme to Be Toxic to Prokaryotic Host Cells

Lysozyme-like Protein Produced by Bifidobacterium longum Regulates Human Gut Microbiota Using In Vitro Models

In vitro PCR verification that lysozyme inhibits nucleic acid replication and transcription

Enhancement of lysozyme trypsin-mediated decay of intestinal bifidobacteria and lactobacilli

An in Vitro Study of Antibacterial Activity of 25 Strains of Probiotics from Human Gastrointestinal Tract

Experimental Study on Bacteriostasis in Vitro of Longliqi DL Toothpaste Containing Compound Enzyme on Several Species of Oral Bacterium

A novel thermophilic lysozyme 4356 from Cohnella sp. A01: Cloning, heterologous expression, biochemical and kinetic characterization

Inhibition of antibiotic-induced lysis and lipopolysaccharide release from Escherichia coli 0111 :B4 by egg white lysozyme